Form 144: NCNO proposed sale of 1.03M shares via Merrill Lynch
Rhea-AI Filing Summary
nCino, Inc. reported a proposed sale under Rule 144 of 1,025,268 shares of its common stock to be executed through Merrill Lynch Pierce Fenner and Smith on 09/08/2025 on Nasdaq, with an aggregate market value of $31,168,147.20 based on the notice. The shares represent securities acquired in a private placement on 06/15/2020 for cash. The filer states there were no securities sold in the past three months for the account and certifies they do not possess undisclosed material adverse information about the issuer. This notice is a regulatory disclosure of an intended insider sale and provides basic transaction details only.
Positive
- Full Rule 144 disclosure provided including share count, acquisition date, acquisition method, broker, and aggregate market value
- No reported sales in the past three months, which clarifies recent trading activity for the account
Negative
- Large proposed sale size of 1,025,268 shares valued at $31,168,147.20, which could have market impact depending on execution
- Limited contextual detail in the notice (no seller identity in excerpt, no per-share price, and no stated 10b5-1 plan date), restricting assessment of timing or motivation
Insights
TL;DR: Insider plans to sell ~1.03M shares valued at $31.17M; disclosure clarifies acquisition source and timing but offers no pricing details.
The Form 144 shows a sizable proposed sale by a holder who acquired the shares in a private placement on 06/15/2020 and intends to route the sale through a major broker on 09/08/2025. The filing confirms no sales in the prior three months, which helps isolate this event. While the notice is transparent about quantity, acquisition date, and aggregate value, it does not state the per-share price or the seller's identity beyond the required fields, limiting assessment of potential market impact. As a regulatory notice, its primary importance is disclosure rather than operational insight.
TL;DR: Form 144 fulfills Rule 144 disclosure for an intended sale; it documents provenance and broker routing but provides limited context.
The filing meets procedural requirements by identifying the class, acquisition method (private placement), acquisition date, and proposed broker. The signer affirms no undisclosed material adverse information, aligning with disclosure obligations. The document lacks details on whether the sale is related to any trading plan or contains signatory identifiers in the provided excerpt, which would further clarify compliance with insider-trading safeguards. As submitted, the notice is a standard governance disclosure without new corporate governance actions disclosed.